Healthy adult
Conditions
Interventions
The treatment group will receive oral administration of three jellies including 2 mg astaxanthin twice daily (12 mg astaxanthin/ 6 jellies /day).
The placebo group will receive oral administration of
Sponsors
JXTG Nippon Oil & energy Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Healthy males and females from 20 to 64 years of age. (2) Subjects who are targeted of high ranks in depression score of POMS2 in (1).
Exclusion criteria
Exclusion criteria: (1) Subjects who are 0mm as a result of VAS stress. (2) Subjects who routinely use food or medicine containing of astaxanthin. (3) Night and day shift worker or manual laborer. (4) Subjects with the smoking custom. (5) Bed time is after 2:00 (6) Subjects who drink much alcohol. (7) Subjects who dose not engage in the periodical labor. (8) Subjects who has got a rash with surgical tape, or may become infected with surgical tape, or that tape is easy to come off. (9) Subjects who have a disease on treatment or are judged to that medical treatment are necessary by the doctor. (10) Subjects who are under treatment or a history of sleep apnea syndrome or are strongly suspected of having sleep apnea syndrome. (11) Subjects diagnosed with chronic fatigue syndrome. (12) Subjects who have treated oral or dental care within the last one month prior to the current study or are planned to treat oral or dental care. (13) Subjects who have oral or dental problems with bleeding. (14) Subjects who were under treatment or have a history of serious diseases(e.g., diabetes, liver disease, kidney disease, or heart disease). (15) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire and other questionnaires. (16) Those who can not carry out the procedures of various tests to be carried out during this study. (17) Subjects having possibilities for emerging allergy related to the study. (18) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination. (19) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study. (20) Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating. I omit (21) for input regulation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Japanese version of POMS2 | — |
Countries
Japan
Contacts
Public ContactMasahiro Hayashi
JXTG Nippon Oil & energy Corporation Biotechniques Group Function materials Research and Development Section Function materials Company
Outcome results
None listed